Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
-
Maxus Mining Engages Understood Mineral Resources to Advance Resource-Focused Work at Quarry Project
-
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Ocean Power Technologies and Stratum Holdings Sign Letter of Intent for Proposed Strategic Collaboration to Demonstrate Offshore Renewable-Powered Data Center Assets
-
Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
-
Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026
-
Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP
-
Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Convening
-
Kailas FUGA Mogan Mountain Running Race Celebrates10 Years
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
'Austin Marketers Connect' Approaches Capacity - Final Opportunity to Join an Exclusive Gathering of B2B Marketing & Growth Leaders
-
Dot Ai Appoints Technology Industry Veteran Avi Cohen to Board of Directors
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
-
Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator
-
Serapha Bio Announces Positive Interim Safety and Efficacy Data from the SERP-01 Investigator-Initiated Trial Presented at the ERS Alpha-1 Antitrypsin Conference 2026
-
HBT Financial, Inc. Announces Third Quarter 2026 Financial Results
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 23 10 2026] - (CGWL)
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Electra Refinery Construction Remains on Budget as Workforce Doubles
-
Lakeland Financial Reports Record Third Quarter Performance with Loan Growth of 8%; Diluted Earnings per Share Increases by 11%
-
Abcourt Mines Produces 740 Ounces of Gold in September
-
Origin Agritech's Three New Corn Varieties Pass Preliminary National Review, Advancing Toward Commercialization
-
ARKO Corp. to Report Third Quarter 2026 Financial Results on November 5, 2026
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Goldera Identifies Large Gold-Tungsten-Antimony Anomaly at Riley Brook, with Multiple Targets Remaining Open
-
Nayax to Report 2026 Q3 Earnings on November 11, 2026
-
AutoZone Chief Financial Officer Jamere Jackson to Depart November 25, 2026
-
Xali Gold Submits FTA Application and Selects Drill Contractor for Pico Machay
-
Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026
-
Xtract One Technologies to Present at Planet MicroCap Toronto 2026 Powered by MicroCapClub
-
Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
-
BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients
-
HighPeak Energy, Inc. Announces 2026 Third Quarter Earnings Release and Conference Call Dates
-
Gildan Completes Sale of HanesBrands Australia
-
Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026
-
Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
-
Origin Agritech's Three New Corn Varieties Pass Preliminary National Review, Advancing Toward Commercialization
-
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
-
ARKO Petroleum Corp. to Report Third Quarter 2026 Financial Results on November 4, 2026
-
Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
-
Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology
-
Verizon Delivers Another Record-Breaking Quarter with 3Q 2026 Results Driven by Strong Postpaid Phone and Account Additions
-
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
-
VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy
-
GXO and Agility Robotics Expand Partnership to Accelerate Deployment of Humanoids in U.S. Operations
-
Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026
-
TILT Biotherapeutics Presents Encouraging Phase 1b Results in Ovarian Cancer at ESMO 2026
-
Centauri Minerals Inc. Begins Trading on OTCQX Best Market
-
Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness
